Answer
It is licensed for advanced renal cell carcinoma and selected subtypes of advanced soft-tissue sarcoma in adults, subject to the treatment-history criteria in the product licence.
Sources for this answer
- Pazopanib 200mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.